Publication | Closed Access

The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates

InfertilityUrologyFertility-sparing TreatmentFertilityLow Live-birth RatesHormonal ContraceptiveReproductive HealthGynecologyMenstrual CycleEndometrial CancerPublic HealthMedicineFertility PreservationWomen's Health